Published date: Feb 11 2020

Journal Title: KnE Life Sciences

Issue title: The 2019 International Conference on Biotechnology and Life Sciences (IC-BIOLIS)

Pages:

DOI: 10.18502/kls.v5i2.6438

Dessy Nurul Jannah PattyBiotechnology Department, Faculty of Health Sciences, Universitas Esa Unggul, Jakarta

Tazkia Ayu SafitriBiotechnology Department, Faculty of Health Sciences, Universitas Esa Unggul, Jakarta

Henny Saraswatihennysaraswati@esaunggul.ac.idBiotechnology Department, Faculty of Health Sciences, Universitas Esa Unggul, Jakarta

Bcl-2 protein (B-cell lymphoma 2) is one of the proteins in the Bcl-2 protein family that are anti apoptotic and encoded by the BCL-2 gene. This protein controls the permeability of the outer membrane of the mitochondria, which plays a role in the release of cytochrome c and several other proteins that contribute to cell death. Bcl-2 protein plays a role in regulating cell death and regulating the balance between new and old cells. Several studies showed that changes in the structure and function of Bcl-2 play a role in cell apoptosis disorders, producing cancer cells. High expression of Bcl-2 protein is seen in lung, breast, lymph node and brain cancers. Analysis of Bcl-2 protein expression at the molecular level in cancer cell is needed to determine the expression level of this protein. This study aims to produce the Bcl-2 primer for qPCR method that specifically identifies the target gene, and can be used to see the BCL-2 gene expression level in cells. A BCL-2 sequence was obtained from the National Center for Biotechnology Information (NCBI). The next process is further analysis with Primer-BLAST (NCBI). Some primer candidates are produced and undergo another selection based on several criteria. Finally, one pair of potential primers was obtained for the reaction of qPCR to BCL-2. Primer specificity was tested with Basic Local Alignment Tools (BLAST) tools and result in specific primer for human BCL-2 gene. Annealing temperature optimization shows that the primer can react optimally at 59^∘C.

Keywords: Bcl-2 protein, BCL-2 gene, qPCR, primer, gene expression, apoptosis

[1] Ola MS, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem. 2011;351(1-2):41-58. doi:10.1007/s11010-010-0709-x.


[2] Youle RJ, Strasser A. The BCL-2 protein family: Opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 2008;9(1):47-59. doi:10.1038/nrm2308.


[3] Tischner D, Woess C, Ottina E, Villunger A. Bcl-2-regulated cell death signalling in the prevention of autoimmunity. Cell Death Dis. 2010;1:e48. doi:10.1038/cddis.2015.400.


[4] Anagnostou V, Lowery F, Zolota V, et al. High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology. BMC Cancer. 2010;10(1):186. http: //www.biomedcentral.com/1471-2407/10/186.


[5] Eom YH, Kim HS, Lee A, Song BJ, Chae BJ. Breast Cancer BCL2 as a Subtype-Specific Prognostic Marker for Breast Cancer. 2016;19(3):252-260.


[6] Gu Y, Pan Y, Meng B, et al. High levels of bcl-2 protein expression do not correlate with genetic abnormalities but predict worse prognosis in patients with lymphoblastic lymphoma. Tumor Biol. 2013;34(3):1441-1450. doi:10.1007/s13277-013-0647-9.
[7] Tischner D, Woess C, Ottina E, Villunger A. Bcl-2-regulated cell death signalling in the prevention of autoimmunity. Cell Death Dis. 2010;1(6):e48-11. doi:10.1038/cddis.2010.27.


[8] Lochmann TL, Floros K V., Naseri M, et al. Venetoclax is effective in small-cell lung cancers with high BCL-2 expression. Clin Cancer Res. 2018;24(2):360-369. doi:10.1158/1078-0432.CCR-17-1606.


[9] Han B, Park D, Li R, et al. Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy. Cancer Cell. 2015;27(6):852-863. doi:10.1016/j.ccell.2015.04.010.


[10] Rooswinkel RW, Van De Kooij B, De Vries E, et al. Antiapoptotic potency of Bcl-2 proteins primarily relies on their stability, not binding selectivity. Blood. 2014;123(18):2806-2815. doi:10.1182/blood-2013- 08-519470.


[11] Protrka Z, Arsenijevic S, Dimitrijevic A, et al. Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions. Eur J Histochem. 2011;55(1):44-49. doi:10.4081/ejh.2011.e8.


[12] Wang Y, Tian RM, Gao ZM, Bougouffa S, Qian PY. Optimal eukaryotic 18S and universal 16S/18S ribosomal RNA primers and their application in a study of symbiosis. PLoS One. 2014;9(3). doi:10.1371/journal.pone.0090053.


[13] BioRad. BioRad: CFX384 / CFX96 Touch TM Real-Time PCR Detection Systems Instruction Manual.; 2013.


[14] Thornton B, Basu C. Real-time PCR (qPCR) primer design using free online software. Biochem Mol Biol Educ. 2011;39(2):145-154. doi:10.1002/bmb.20461.


[15] Bustin S, Huggett J. qPCR primer design revisited. Biomol Detect Quantif. 2017;14(March):19-28. doi:10.1016/j.bdq.2017.11.001.


[16] Sanders R, Bustin S, Huggett J, Mason D. Improving the standardization of mRNA measurement by RT-qPCR. Biomol Detect Quantif. 2018;15(August 2017):13-17. doi:10.1016/j.bdq.2018.03.001.